Pharma major Dr. Reddy's Laboratories today said it has launched Fenofibrate capsules, a therapeutic equivalent generic version of Antara capsules, in the USA market.
The drug which is indicated to reduce cholesterol and triglycerides (fatty acids) in the blood was approved by the United States Food & Drug Administration (USFDA), DRL said in a statement.
The Antara (fenofibrate) capsules brand and generic had U.S. Sales of approximately USD 74 Million MAT for the most recent twelve months ending in February 2014 according to IMS Health.
Dr. Reddy's Fenofibrate capsules, USP 43 mg is available in bottle counts of 30, and 130 mg are available in bottle counts of 30 and 90, the drug maker said.
